North­way Biotech sets up shop in Boston hub, look­ing to court more cus­tomers with bi­o­log­ics-fo­cused plant

Get­ting a foot in the door in Boston’s bustling bio­phar­ma hub is a rite of pas­sage for many com­pa­nies, but it comes with a steep price tag. Lithuan­ian CD­MO North­way — now with a new moniker — will set up a new plant in close prox­im­i­ty, and it’s hop­ing its bi­o­log­ics fo­cus will find a will­ing cus­tomer base.

North­way Biotech (for­mer­ly North­way Biotech­phar­ma) on Wednes­day held a vir­tu­al grand open­ing cer­e­mo­ny for its $40 mil­lion Waltham, MA fa­cil­i­ty — a 30,000 square-foot cGMP man­u­fac­tur­ing and process de­vel­op­ment plant that will wide­ly ex­pand on the com­pa­ny’s pre­vi­ous ca­pa­bil­i­ties.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER